Yarrow Bioscience (YARW) Total Debt (2019 - 2021)

Yarrow Bioscience (YARW) has reported Total Debt for 3 consecutive years, with $33.4 million the latest figure, recorded in Q2 2021.

• For the quarter ending Q2 2021, Total Debt rose 1.4% year-over-year to $33.4 million; the trailing twelve-month figure through Jun 2021 stood at $33.4 million (up 1.4% YoY), and the FY2020 full-year result was $33.2 million, up 1.37% from the prior year.
• Total Debt eased to $33.4 million in Q2 2021 per YARW's latest filing, from $35.0 million in the prior quarter.
• Across five years, Total Debt topped out at $53.6 million in Q1 2020 and bottomed at $32.7 million in Q4 2019.
• Historically, Total Debt has averaged $36.3 million across 3 years, with a median of $33.2 million in 2020.
• The widest YoY moves for Total Debt: up 1.4% in 2021, down 34.76% in 2021.
• Over 3 years, Total Debt stood at $32.7 million in 2019, then advanced by 1.37% to $33.2 million in 2020, then rose by 0.61% to $33.4 million in 2021.
• According to Business Quant data, Total Debt over the past three periods registered $33.4 million, $35.0 million, and $33.2 million for Q2 2021, Q1 2021, and Q4 2020 respectively.